1.37
price up icon5.38%   0.07
 
loading
Precedente Chiudi:
$1.30
Aprire:
$1.29
Volume 24 ore:
22,042
Relative Volume:
0.23
Capitalizzazione di mercato:
$3.91M
Reddito:
$202.00K
Utile/perdita netta:
$-28.96M
Rapporto P/E:
-2.2833
EPS:
-0.6
Flusso di cassa netto:
$-21.85M
1 W Prestazione:
-2.84%
1M Prestazione:
-47.51%
6M Prestazione:
+1,344%
1 anno Prestazione:
+547.14%
Intervallo 1D:
Value
$1.26
$1.37
Intervallo di 1 settimana:
Value
$1.26
$1.4598
Portata 52W:
Value
$0.0633
$20.35

AIM ImmunoTech Inc Stock (AIM) Company Profile

Name
Nome
AIM ImmunoTech Inc
Name
Telefono
352 448 7797
Name
Indirizzo
2117 SW Highway 484, Ocala, FL
Name
Dipendente
24
Name
Cinguettio
@AIMImmuno
Name
Prossima data di guadagno
2024-12-15
Name
Ultimi documenti SEC
Name
AIM's Discussions on Twitter

Confronta AIM con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
AIM
AIM ImmunoTech Inc
1.37 3.59M 202.00K -28.96M -21.85M -0.60
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.76 107.15B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
755.90 77.46B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
436.38 58.90B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
918.92 56.55B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
198.76 42.58B 447.02M -1.18B -906.14M -6.1812

AIM ImmunoTech Inc Borsa (AIM) Ultime notizie

pulisher
Nov 21, 2025

What analyst consensus implies for AIM ImmunoTech Inc. (HXB) stock2025 Fundamental Recap & Daily Volume Surge Trade Alerts - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Why global investors buy AIM ImmunoTech Inc. stockWeekly Stock Report & Daily Oversold Bounce Ideas - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Why AIM ImmunoTech Inc. stock fits value portfoliosJuly 2025 Levels & Community Trade Idea Sharing Platform - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will AIM ImmunoTech Inc. (HXB) stock deliver stable dividends2025 Technical Overview & Risk Adjusted Buy/Sell Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

How AIM ImmunoTech Inc. (HXB) stock behaves under inflation pressureMarket Movers & Real-Time Chart Breakout Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is AIM ImmunoTech Inc. (HXB) stock vulnerable to rate hikesQuarterly Portfolio Report & Safe Capital Growth Tips - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Can AIM ImmunoTech Inc. stock deliver strong annual returnsJuly 2025 Highlights & AI Based Buy/Sell Signal Reports - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Is AIM ImmunoTech Inc. stock a buy on weaknessJuly 2025 Movers & Real-Time Volume Analysis - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can AIM ImmunoTech Inc. (HXB) stock resist broad market declines2025 Market Outlook & Technical Pattern Alert System - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is AIM ImmunoTech Inc. (HXB) stock bottoming after sell offGDP Growth & Step-by-Step Trade Execution Guides - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

AIM ImmunoTech Enters Note Purchase Agreement - TipRanks

Nov 19, 2025
pulisher
Nov 19, 2025

Aim ImmunoTech enters Note Purchase Agreement with Streeterville Capital, says SEC filing - MarketScreener

Nov 19, 2025
pulisher
Nov 19, 2025

Is AIM ImmunoTech Inc. stock a buy before new product rollout2025 Price Targets & Precise Trade Entry Recommendations - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is AIM ImmunoTech Inc. (HXB) stock resilient in recession scenariosJuly 2025 Volume & Trade Opportunity Analysis Reports - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

AIM ImmunoTech Reports Third Quarter 2025 Financial Results and Highlights Continued Progress Across Pipeline with Strategic Focus on Pancreatic Cancer Clinical Program - The Manila Times

Nov 18, 2025
pulisher
Nov 18, 2025

AIM ImmunoTech reports third quarter 2025 financial results and highlights continued progress across pipeline with strategic focus on pancreatic cancer clinical program - MarketScreener

Nov 18, 2025
pulisher
Nov 18, 2025

AIM ImmunoTech (NYSE American: AIM) Q3 2025 highlights pancreatic cancer Ampligen program, $2.4M cash - Stock Titan

Nov 18, 2025
pulisher
Nov 17, 2025

AIM ImmunoTech Reports Q3 2025 Financial Results - TipRanks

Nov 17, 2025
pulisher
Nov 17, 2025

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Nov 17, 2025
pulisher
Nov 17, 2025

Can AIM ImmunoTech Inc. stock expand revenue streamsWeekly Stock Analysis & Capital Efficiency Focused Ideas - newser.com

Nov 17, 2025

AIM ImmunoTech Inc Azioni (AIM) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$38.92
price up icon 1.38%
$30.45
price up icon 1.36%
$102.06
price up icon 0.29%
$95.59
price down icon 1.42%
biotechnology ONC
$347.72
price down icon 0.45%
$198.76
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):